The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
meda pharma & company | 215 |
almirall | 35 |
novartis | 17 |
meda | 17 |
viatris & company | 12 |
medivir | 10 |
wirra ip | 9 |
valeant pharmaceuticals north amer… 🛈 | 7 |
meda farma gmbkh und ko.kg | 5 |
novartis pharmaceuticals | 4 |
meda pharma & company | 10 |
almirall | 1 |
sofotec & company | 1 |
laboratorios almirall | 1 |
viatris & company | 1 |
novartis | 1 |
meda | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflamma… 🛈 | 30 | 2005 |
powder formulation disintegrating system and dry powder inhalers | 23 | 2001 |
treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline … 🛈 | 19 | 2008 |
combinations of potassium channel openers and sodium channel inhibitors or active substa… 🛈 | 19 | 2003 |
combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treat… 🛈 | 18 | 2004 |
heteroatoms-containing tricyclic compounds | 17 | 2004 |
nasal pharmaceutical formulation comprising fluticasone | 17 | 2011 |
storage system for medicaments in powder form and inhaler provided therewith | 17 | 1999 |
the combination of anticholinergics and leukotriene receptor antagonists for the treatme… 🛈 | 16 | 2005 |
a multidose package, course and method of treatment for delivering predetermined multipl… 🛈 | 15 | 2009 |